home / stock / akro / akro news

AKRO News and Press, Akero Therapeutics Inc. From 07/07/20

Stock Information
Company Name: Akero Therapeutics Inc.
Stock Symbol: AKRO
Market: NASDAQ
Website: akerotx.com
Menu
AKRO AKRO Quote AKRO Short AKRO News AKRO Articles AKRO Message Board
Get AKRO Alerts

News, Short Squeeze, Breakout and More Instantly...
AKRO - Akero Therapeutics Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif. , July 7, 2020 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic non-alcoholic steatohepatitis (NASH) company developing pioneering medicines designed to restore metabolic balance and improve the overall health of NASH patients,&#...
AKRO - Akero Therapeutics readies equity offering

Akero Therapeutics (NASDAQ: AKRO ) has commenced a public offering of 4.75M common shares. More news on: Akero Therapeutics, Inc., Healthcare stocks news, , Read more ...

AKRO - Akero Therapeutics Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif. , July 6, 2020 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic non-alcoholic steatohepatitis (NASH) company developing pioneering medicines designed to restore metabolic balance and improve the overall health of NASH patients, a...

AKRO - Corcept's Phase 3 Trial, And Other News: The Good, Bad And Ugly Of Biopharma

Corcept Therapeutics Starts Phase 3 Pancreatic Cancer Trial Corcept Therapeutics Inc. ( CORT ) announced enrollment of the first participant in its Phase 3 trial RELIANT. The trial seeks to evaluate relacorilant in conjunction with nab-paclitaxel for treating patients with metastatic pan...
AKRO - Akero Therapeutics (AKRO) Reports Biopsy Data and Safety/Tolerability for 16-Week Phase 2a Study in NASH Patients - Slideshow

The following slide deck was published by Akero Therapeutics, Inc. in conjunction with this Read more ...

AKRO - TTOO, MMLP, INO and BLNK among midday movers

Gainers: MYOS RENS Technology (NASDAQ: MYOS ) +210% . More news on: MYOS RENS Technology Inc., Liminal BioSciences Inc., YRC Worldwide Inc., Stocks on the move, , Read more ...

AKRO - FDX, BYND among premarket gainers

YRC Worldwide (NASDAQ: YRCW ) +123%  on receiving $700M CARES act loan from U.S. Treasury. More news on: YRC Worldwide Inc., T2 Biosystems, Inc., Akero Therapeutics, Inc., Stocks on the move, , Read more ...

AKRO - Akero reports additional positive data on lead candidate in NASH patients

Akero Therapeutics (NASDAQ: AKRO ) jumps  +43%  AH, after the company announce results of a 16-week analysis of secondary and exploratory endpoints from its Phase 2a BALANCED study of its lead candidate efruxifermin (EFX), formerly known as AKR-001, in nonalcoholic steatohepatiti...

AKRO - UPS, FDX, GNW and AKCA among after-hours movers

Gainers:  AKRO +33.8% . ETNB +21.1% . FDX +8.9% . AKCA +5.8% . UPS +5.0% . More news on: Akero Therapeutics, Inc., 89bio, Inc., FedEx Corporation, Stocks on the move, , Read more ...

AKRO - Akero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients

SOUTH SAN FRANCISCO, Calif. , June 30, 2020 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO) today announced results of a 16-week analysis of secondary and exploratory endpoints in its Phase 2a BALANCED study of efruxifermin (EFX), formerly known as AKR-001, in patients with n...
Previous 10 Next 10